ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026
The scope and impact of Walking the Talk for Dementia 2024.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Walking the talk for dementia: building social networks and collaborations.Implementation science communications · 2026Article
- The scope and impact of Walking the Talk for Dementia 2024.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- "I wasn't broken": Addressing stigma associated with dementia while Walking the Talk for Dementia.Alzheimer's & dementia (Amsterdam, Netherlands)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionWalking the Talk for Dementia (WTD) is a global educational initiative integrating a walk along the Camino de Santiago with a symposium to combat dementia stigma, raise awareness, and foster inclusion.
methodsA mixed-methods, community-engaged study assessed the impact of WTD 2024 on participants. Data were gathered via pre- and post-event surveys, personal reflections, and social network analysis.
resultsSeventy-nine participants representing 27 countries of origin participated in the study. Key findings highlighted transformative learning, creation of a community with shared interests, enhanced advocacy, new collaborations, and leadership development. Participants reported greater empathy for people living with dementia and their care partners, deeper knowledge of dementia, and stronger personal commitment to inclusive practices. DISCUSSION: WTD 2024 cultivated cross-cultural collaboration and connection among diverse stakeholders. The initiative spurred innovative advocacy approaches, reinforced person-centered care principles, and provided a scalable model for participatory dementia programs. HIGHLIGHTS: Walking the Talk for Dementia (WTD) 2024 combined multiple dimensions to transform perspectives on dementia. This research found high satisfaction, new collaborations, and individual impact. WTD integrated experiences of dementia in a journey of exploration and learning WTD enhanced empathy, personal purpose, and commitment to brain health advocacy. The WTD model has potential for global dissemination and influence on dementia policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.